Navigation Links
MMV and SCYNEXIS offer 400 active compounds for neglected disease drug research at no cost
Date:12/19/2011

sident & CEO of SCYNEXIS, Inc. "SCYNEXIS stands ready to direct its proprietary technologies including its Integrated Parasitology Screening Platform and its HEOS Collaborative Discovery Information Software Platform along with its highly experienced drug discovery teams to find innovative cures for these diseases."

The Malaria Box can be requested free-of-charge from MMV's website. All that is asked in return is that any data gleaned from research on the Box is published, shared and placed into the public domain to continue the virtuous cycle of research.


'/>"/>
Contact: Jaya Banerji
banerjij@mmv.org
41-079-707-7181
Medicines for Malaria Venture
Source:Eurekalert

Page: 1 2

Related biology news :

1. BI-Clinical Offers 100% Coverage of All ACO Quality Measures Released by CMS
2. Ancient dry spells offer clues about the future of drought
3. Cheap beads offer alternative solar-heating storage
4. 2 top biological imaging centers offer powerful free online tool to researchers and public
5. Submarine springs offer preview of ocean acidification effects on coral reefs
6. BI-Clinical Offers 100% Coverage of All ACO Quality Measures Released by CMS
7. Targeted antibacterial proteins may offer antibiotic alternative
8. Novel monoclonal antibody offers potential treatment for tumors resistant to VEGF therapy
9. Ultrathin flexible brain implant offers unique look at seizures in NIH-funded research
10. New report offers broad approach to assessing impacts of ecological damage
11. Evolution offers clues to leading cause of death during childbirth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2015)... , July 23, 2015 Research and ... of the "Global Outlook of the Biometrics ... The global biometrics market is ... and commercial applications owing to the uptake of ... a transformation that enhances the growth of biometrics ...
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet, announces that it has filed provisional patent ... Method. This invention highlights next ... authorizes an account, but also the user using ...
(Date:7/20/2015)...  Acuity Market Intelligence,s latest research "The Global ... and Privacy" forecasts that between 2014 and 2020 ... downloaded to smart mobile devices by 2.2 billion ... projected to generate more than $67.9 billion in ... period.    "Biometrics is at the ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... of powerful supercomputers capable of analyzing decades of ... a technological milestone capable of bringing comprehensive changes ... at the University of Miami,s Rosenstiel School of ... Center for Atmospheric Research), COLA (Center for Ocean-Land-Atmospheric ...
... cell research is the next great leap in medicine. In ... a failing heart, or new cells take the place of ... from embryonic sources, which opens difficult ethical and complicated scientific ... culled from a person,s own body. Adult stem cells are ...
... 4, 2008) The tumor suppressor gene pRb2/p130 ... cases of soft tissue sarcoma (STS), according to ... the Sbarro Institute for Cancer Research and Molecular ... at Temple University in Philadelphia, PA, the Department ...
Cached Biology News:Petascale climate modeling heats up at University of Miami 2Petascale climate modeling heats up at University of Miami 3Tel Aviv University researchers create new stem cell screening tool 2International team reveals first prognosticator of survival in aggressive cancer 2
(Date:7/28/2015)... July 21, 2015 ... the addition of the "Analysis of the ... their offering. Globally, flow cytometry remains ... cell proliferation, cancer, and stem cells. But the ... primarily because of demand from underdeveloped nations to ...
(Date:7/28/2015)... July 28, 2015  Kerastem Technologies announce that the ... U.S. FDA Center For Biologics Evaluation and Research (CBER) ... a clinical trial investigating the safety and feasibility of ... early male pattern baldness (androgenic alopecia). The ... initial clinical work in Europe ...
(Date:7/28/2015)... N.C., July 28, 2015  United Therapeutics Corporation (NASDAQ: ... for the second quarter ended June 30, 2015. ... compared to the second quarter of 2014 when ... Ph.D., United Therapeutics, President and Co-Chief Executive Officer. ... an increase in the number of patients being ...
(Date:7/27/2015)... 27, 2015 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ... commercializing products for the treatment of cancer, today provides ... it has closed a $1,000,000 unit offering private placement.  ... units of the Company at a price of $0.06 ... share and one common share purchase warrant.  Each whole ...
Breaking Biology Technology:Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Kerastem Receives Conditional Approval from FDA for Alopecia Trial 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11Quest PharmaTech Closes $1,000,000 Private Placement 2
... SOUTH SAN FRANCISCO, Calif., Nov. 1, 2010 diaDexus, ... diagnostics company focused on the development and commercialization of ... needs in cardiovascular disease, today announced that the company, ... OTC Bulletin Board under the ticker symbol (VXGN), has ...
... AMGN ) Senior Vice President of Research and ... U.S. Food and Drug Administration (FDA) panel charged with implementing ... patient safety and follow a science-based approach. "Put ... "Amgen believes biosimilars have a meaningful role to play in ...
... ... ... var shortURL = ... need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var ...
Cached Biology Technology:diaDexus Announces Name Change From VaxGen 2diaDexus Announces Name Change From VaxGen 3Amgen to Provide Testimony at FDA Hearing on Biosimilars 2Amgen to Provide Testimony at FDA Hearing on Biosimilars 3Amgen to Provide Testimony at FDA Hearing on Biosimilars 4NEURO-BIOTECH CORPORATION: Updates and latest developments 2NEURO-BIOTECH CORPORATION: Updates and latest developments 3NEURO-BIOTECH CORPORATION: Updates and latest developments 4NEURO-BIOTECH CORPORATION: Updates and latest developments 5NEURO-BIOTECH CORPORATION: Updates and latest developments 6NEURO-BIOTECH CORPORATION: Updates and latest developments 7NEURO-BIOTECH CORPORATION: Updates and latest developments 8NEURO-BIOTECH CORPORATION: Updates and latest developments 9
Src cDNA Expression Kit (wild type)...
...
Chicken polyclonal to ADI1 ( Abpromise for all tested applications). Antigen: Full length native protein (purified), corresponding to amino acids 1-179 of Human ADI1. Entrez GeneID: 55256 ...
ABI Plant AFLP Kits • EcoRI-ACA AFLP Amplification Primers...
Biology Products: